Synopsys Inc. Files 8-K on Equity Sales and Disclosures

Ticker: SNPS · Form: 8-K · Filed: 2025-12-01T00:00:00.000Z

Sentiment: neutral

Topics: equity-sale, disclosure, financials

Related Tickers: SNPS

TL;DR

Synopsys filed an 8-K on Dec 1, 2025, covering equity sales and financial info.

AI Summary

Synopsys Inc. filed an 8-K on December 1, 2025, reporting on unregistered sales of equity securities, Regulation FD disclosures, and financial statements/exhibits. The filing details the company's principal executive offices located at 675 Almanor Ave, Sunnyvale, California, 94085.

Why It Matters

This filing provides important updates on Synopsys's financial activities and regulatory compliance, which can influence investor decisions.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate events and financial information, not indicating immediate operational or financial distress.

Key Players & Entities

FAQ

What specific type of equity securities were sold unregistered?

The filing does not specify the type of equity securities sold unregistered, only that it is an item being reported.

What are the key financial statements or exhibits included in this filing?

The filing indicates that 'Financial Statements and Exhibits' are included, but does not list their specific titles or content.

What is the significance of the 'Regulation FD Disclosure' item?

Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, suggesting this filing may contain such information.

What is Synopsys Inc.'s fiscal year end?

Synopsys Inc.'s fiscal year ends on October 31st.

What is the Commission File Number for Synopsys Inc.?

The Commission File Number for Synopsys Inc. is 000-19807.

From the Filing

0001193125-25-303209.txt : 20251201 0001193125-25-303209.hdr.sgml : 20251201 20251201084917 ACCESSION NUMBER: 0001193125-25-303209 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20251201 ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251201 DATE AS OF CHANGE: 20251201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNOPSYS INC CENTRAL INDEX KEY: 0000883241 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology EIN: 561546236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19807 FILM NUMBER: 251537354 BUSINESS ADDRESS: STREET 1: 675 ALMANOR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 6505845000 MAIL ADDRESS: STREET 1: 675 ALMANOR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 8-K 1 d36680d8k.htm 8-K 8-K SYNOPSYS INC false 0000883241 0000883241 2025-12-01 2025-12-01     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2025     SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter)       Delaware   000-19807   56-1546236 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification Number) 675 Almanor Ave. Sunnyvale , California 94085 (Address of Principal Executive Offices) (Zip Code) (650) 584-5000 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of Class   Trading Symbol(s)   Name of each exchange on which registered Common Stock (par value of $0.01 per share)   SNPS   Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging Growth Company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 3.02 Unregistered Sales of Equity Securities. On December 1, 2025, Synopsys, Inc. (“ Synopsys ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with NVIDIA Corporation (“ NVIDIA ”). Pursuant to the Purchase Agreement, NVIDIA purchased 4,821,717 shares of Synopsys’ common stock, par value $0.01 per share (the “ Shares ”), at a price per share of $414.79, for an aggregate purchase price of $2 billion in cash. The Shares are being issued to NVIDIA in a private placement relying upon the exemption provided by Section 4(

View on Read The Filing